Brief: Implanet Receives FDA Clearance For JAZZ Cap System
March 19 (Reuters) - IMPLANET SA ALIMP.PA :
* RECEIVED 510(K) AUTHORIZATION FROM FOOD AND DRUG
ADMINISTRATION
(FDA) FOR ITS JAZZ CAP SYSTEM
* CLEARANCE IS A KEY COMPONENT IN PRIVATE LABEL DISTRIBUTION
AGREEMENT SIGNED WITH SEASPINE HOLDINGS CORPORATION (NASDAQ;
SPNE) ANNOUNCED IN FEBRUARY
Source text for Eikon: ID:nBw6mkjGPa
Further company coverage: ALIMP.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Implanet SA
See all newsFrench orthopedic implants maker Implanet's nine-month revenue jumps, partly on strong US momentum
French and Benelux stocks-Factors to watch on September 16
France's IMPLANET H1 revenue rises on medical equipment strength, US growth
Brief: IMPLANET H1 Revenue EUR 7.1 Million
France's IMPLANET H1 revenue rises on spine implants strength, US growth